Cantitate/Preț
Produs
Total produse
Vezi coșul
Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice? de Germán Velásquez

Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice?: SpringerBriefs in Public Health

Autor Germán Velásquez
en Limba Engleză Paperback – 25 dec 2021
This open access book is a collection of research papers on COVID-19 by Germán Velásquez from 2020 and early 2021 that help to answer the question: How can an agency like the World Health Organization (WHO) be given a stronger voice to exercise authority and leadership? 

The considerable health, economic and social challenges that the world faced at the beginning of 2020 with COVID-19 continued and worsened in many parts of the world in the second-half of 2020 and into 2021. Many of these countries and nations wanted to explore COVID-19 on their own, sometimes without listening to the main international health bodies such as WHO, an agency of the United Nations system with long-standing experience and vast knowledge at the global level and of which all countries in the world are members. 

In this single volume, the chapters present the progress of thinking and debate — particularly in relation to drugs and vaccines — that wouldenable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered:
  • COVID-19 Vaccines: Between Ethics, Health and Economics
  • Medicines and Intellectual Property: 10 Years of the WHO Global Strategy
  • Re-thinking Global and Local Manufacturing of Medical Products After COVID-19
  • Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock
  • Intellectual Property and Access to Medicines and Vaccines
  • The World Health Organization Reforms in the Time of COVID-19
Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice? is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO); World Trade Organization (WTO) and World Intellectual Property Organization (WIPO) staff participating in these negotiations; academics and students of public health, medicine, health sciences, law, sociology and political science; and intergovernmental organizations and non-governmental organizations that follow the issue of access to treatments and vaccines for COVID-19.
Citește tot Restrânge

Din seria SpringerBriefs in Public Health

  • 5% Identifying and Addressing Childhood Food Insecurity in Healthcare and Community Settings
    Preț: 12205 lei
  • 5% Elimination of Infectious Diseases from the South-East Asia Region: Keeping the Promise
    Preț: 37909 lei
  • 5% Global Child Health: A Toolkit to Address Health Disparities
    Preț: 12196 lei
  • 5% To Do or Not to Do a PhD?: Insight and Guidance from a Public Health PhD Graduate
    Preț: 33770 lei
  • Sexual and Reproductive Health and Rights in India: Self-care for Universal Health Coverage
    Preț: 25009 lei
  • 5% Tuberculosis in Adults and Children
    Preț: 15834 lei
  • 5% Healthcare Partnerships for Pediatric Adherence: Promoting Collaborative Management for Pediatric Chronic Illness Care
    Preț: 34944 lei
  • 5% Practical Strategies for Clinical Management of Bullying
    Preț: 34294 lei
  • 5% Rural Health Disparities: Public Health, Policy, and Planning Approaches
    Preț: 43412 lei
  • 5% Child Sexual Abuse: Current Evidence, Clinical Practice, and Policy Directions
    Preț: 34682 lei
  • 5% Case Management and Care Coordination: Supporting Children and Families to Optimal Outcomes
    Preț: 37626 lei
  • 5% Integrative Health Services: Ethics, Law, and Policy for the New Public Health Workforce
    Preț: 37343 lei
  • 5% Homeless Youth of Pakistan: Survival Sex and HIV Risk
    Preț: 34557 lei
  • 5% International Adoption and Clinical Practice
    Preț: 34399 lei
  • 5% Autoimmune Disease: Pathogenesis, Genetics, Immunotherapy, Prophylaxis and Principles for Organ Transplantation
    Preț: 34329 lei
  • 5% Disparities in Child Health: A Solutions-Based Approach
    Preț: 37343 lei
  • 5% Culture and Health Disparities: Evaluation of Interventions and Outcomes in the U.S.-Mexico Border Region
    Preț: 34434 lei
  • 5% Successful Public Health Advocacy: Lessons Learned from Massachusetts Legislators
    Preț: 40398 lei
  • 5% A Systematic Review of Rural Development Research: Characteristics, Design Quality and Engagement with Sustainability
    Preț: 34329 lei
  • 5% COVID-19 in New York City: An Ecology of Race and Class Oppression
    Preț: 40486 lei
  • 5% The Complete Resource on Pediatric Office Emergency Preparedness
    Preț: 34626 lei
  • 5% The Recurrence of COVID-19 in New York State and New York City: Surfing the Second Wave
    Preț: 37521 lei
  • Building a Culture of Health: A New Imperative for Business
    Preț: 46346 lei
  • 5% COVID-19 and Health System Segregation in the US: Racial Health Disparities and Systemic Racism
    Preț: 39796 lei
  • 5% Indoor Air Quality in Healthcare Facilities
    Preț: 40800 lei
  • 5% Biogeogens and Human Health
    Preț: 31365 lei
  • 5% Place and Health as Complex Systems: A Case Study and Empirical Test
    Preț: 43537 lei
  • 5% Public Health Ethics and the Social Determinants of Health
    Preț: 34274 lei
  • 5% Mortality and Its Risk Factors Among Professional Athletes: A Comparison Between Former NBA and NFL Players
    Preț: 34731 lei
  • Naturally Based Biomaterials and Therapeutics: The Case of India
    Preț: 36393 lei
  • 5% Grantsmanship for New Investigators
    Preț: 37645 lei
  • 5% Food Democracy: From consumer to food citizen
    Preț: 34309 lei
  • 5% Oral Health and Herbal Medicine
    Preț: 37274 lei
  • 5% Negotiating Public Health in a Globalized World: Global Health Diplomacy in Action
    Preț: 41064 lei
  • 5% Mortality Among Hispanic and African-American Players After Desegregation in Major League Baseball
    Preț: 34696 lei
  • 5% Medical Applications for Biomaterials in Bolivia
    Preț: 34329 lei
  • 5% Personalised Health Care: Fostering Precision Medicine Advancements for Gaining Population Health Impact
    Preț: 34682 lei
  • 5% A Guide to Integrative Pediatrics for the Healthcare Professional
    Preț: 34504 lei
  • 5% HIV and Young People: Risk and Resilience in the Urban Slum
    Preț: 48532 lei
  • The Bright Side and the Dark Side of Patient Empowerment: Co-creation and Co-destruction of Value in the Healthcare Environment
    Preț: 36320 lei
  • 5% From Justice to Protection: A Proposal for Public Health Bioethics
    Preț: 31498 lei
  • Promoting Aboriginal Health: The Family Wellbeing Empowerment Approach
    Preț: 45697 lei
  • 5% Child Physical Abuse: Current Evidence, Clinical Practice, and Policy Directions
    Preț: 40905 lei
  • 5% Toward a Small Family Ethic: How Overpopulation and Climate Change Are Affecting the Morality of Procreation
    Preț: 37378 lei
  • 5% Cultural Competence in Health: A Review of the Evidence
    Preț: 34751 lei
  • 5% Understanding and Managing Vaccine Concerns
    Preț: 34205 lei
  • Medical Devices and Biomaterials for the Developing World: Case Studies in Ghana and Nicaragua
    Preț: 36485 lei
  • The Economics of Epidemiology
    Preț: 42690 lei
  • 5% Application of Systems Thinking to Health Policy & Public Health Ethics: Public Health and Private Illness
    Preț: 34539 lei

Preț: 23831 lei

Preț vechi: 25085 lei
-5% Nou

Puncte Express: 357
Preț estimativ în valută:
4561€ • 4812$ • 3801£

Carte tipărită la comandă

Livrare economică 02-16 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783030891244
ISBN-10: 3030891240
Pagini: 117
Ilustrații: XVI, 117 p.
Dimensiuni: 155 x 235 mm
Greutate: 0.2 kg
Ediția:1st ed. 2022
Editura: Springer International Publishing
Colecția Springer
Seria SpringerBriefs in Public Health

Locul publicării:Cham, Switzerland

Cuprins

Chapter 1: COVID-19 Vaccines: Between Ethics, Health and Economics.- Chapter 2: Medicines and Intellectual Property: 10 Years of the WHO Global Strategy.- Chapter 3: Re-thinking Global and Local Manufacturing of Medical Products After COVID-19.- Chapter 4: Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock.- Chapter 5: Intellectual Property and Access to Medicines and Vaccines.- Chapter 6: The World Health Organization Reforms in the Time of COVID-19.- Epilogue.

Notă biografică

Germán Velásquez is, since 2010, the Special Adviser for Policy and Health of the South Centre in Geneva, Switzerland, which is an intergovernmental think tank of and for developing countries.  

Until May 2010, he was Director of the World Health Organization (WHO) Secretariat on Public Health, Innovation and Intellectual Property, at the Director-General’s Office, in Geneva. He is a pioneer in the new area on health, intellectual property and access to medicines, and he represented WHO at the World Trade Organization (WTO) Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) from 2001 to 2010.

Germán Velásquez graduated from Javeriana University, Bogotá, Colombia, with a degree in Philosophy and Humanities that was further complemented by a Master’s in Economics and a PhD in Health Economics from the Sorbonne University in Paris, France. In 2010, he received a PhD Honoris Causa on Public Health from the University of Caldas, Colombia. In October 2015, he received a Honoris Causa Doctorate from the Faculty of Medicine of the Complutense University of Madrid, Spain.

Germán Velásquez is author or co-author of numerous publications on subjects such as health economics and medicines, health insurance schemes, globalisation, international trade agreements, intellectual property and access to medicines.  

Textul de pe ultima copertă

This open access book is a collection of research papers on COVID-19 by Germán Velásquez from 2020 and early 2021 that help to answer the question: How can an agency like the World Health Organization (WHO) be given a stronger voice to exercise authority and leadership? 

The considerable health, economic and social challenges that the world faced at the beginning of 2020 with COVID-19 continued and worsened in many parts of the world in the second-half of 2020 and into 2021. Many of these countries and nations wanted to explore COVID-19 on their own, sometimes without listening to the main international health bodies such as WHO, an agency of the United Nations system with long-standing experience and vast knowledge at the global level and of which all countries in the world are members. 

In this single volume, the chapters present the progress of thinking and debate — particularly in relation to drugs and vaccines — thatwould enable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered:
  • COVID-19 Vaccines: Between Ethics, Health and Economics
  • Medicines and Intellectual Property: 10 Years of the WHO Global Strategy
  • Re-thinking Global and Local Manufacturing of Medical Products After COVID-19
  • Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock
  • Intellectual Property and Access to Medicines and Vaccines
  • The World Health Organization Reforms in the Time of COVID-19
Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice? is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO); World Trade Organization (WTO) and World Intellectual Property Organization (WIPO) staff participating in these negotiations; academics and students of public health, medicine, health sciences, law, sociology and political science; and intergovernmental organizations and non-governmental organizations that follow the issue of access to treatments and vaccines for COVID-19.

Caracteristici

Explores a rethinking of global and local manufacturing of medical products after COVID-19 Argues that it's time to re-design the global public health governance for health R&D Discusses the lessons of COVID-19 for WHO and the necessary measures that a reform of WHO would have to take This book is open access, which means that you have free and unlimited access